Narcolepsy in association with pandemic influenza vaccination – a multi-country European epidemiological investigation
This report summarises the results from two epidemiological studies conducted by the Vaccine Adverse Event Surveillance and Communication (VAESCO) Consortium undertaken in eight European Union (EU)/European Economic Area (EEA) countries in order to investigate a possible association between an unexpected increase in narcolepsy cases following the use of influenza A(H1N1)pdm09 vaccines. Narcolepsy is an underdiagnosed disease of widely unknown etiology.
Technical report In Brief: Narcolepsy in association with pandemic influenza vaccination
This report summarises the results from two epidemiological studies to investigate a possible association between an unexpected increase in narcolepsy cases following the use of the influenza A(H1N1)pdm09 vaccines. The studies were conducted by the Vaccine Adverse Event Surveillance and Communication (VAESCO) Consortium under the auspices of ECDC and undertaken in Denmark, Finland, France, Italy, the Netherlands, Norway, Sweden and the United Kingdom. This Technical Report In Brief accompanies the full Report ‘Narcolepsy in association with pandemic influenza vaccination- A multi-country European epidemiological investigation’.
Vaccine hesitancy among healthcare workers and their patients in Europe
The aim of this research project is to have a better understanding of vaccine hesitancy and safety concerns among healthcare vaccine providers and their patients in Europe and to explore the link and potential influence between the two groups.
Expert opinion on rotavirus vaccination in infancy
ECDC has published an Expert Opinion on rotavirus vaccination in infancy. The paper provides EU/EEA Member States with relevant scientific information on burden of rotavirus disease, vaccine effectiveness and safety, and cost-effectiveness studies to support the decision-making process on the possible introduction of routine vaccination of children against rotavirus gastroenteritis.
Guillain-Barré syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccines: A multinational self-controlled case series in Europe
Romio, S., Weibel, D., Dieleman, J.P., Olberg, H.K., de Vries, C.S., Sammon, C., rews, N., Svanström, H., Mølgaard-Nielsen, D., Hviid, A., Lapeyre-Mestre, M., Sommet, A., Saussier, C., Castot, A., Heijbel, H., Arnheim-Dahlström, L., Sparen, P., Mosseveld, M., Schuemie, M., van der Maas, N., Jacobs, B.C., Leino, T., Kilpi, T., Storsaeter, J., Johansen, K., Kramarz, P., Bonhoeffer, J., Sturkenboom, M.C.J.M.
Lessons learnt from pandemic A(H1N1) 2009 influenza vaccination. Highlights of a European workshop in Brussels (22 March 2010)
Hanquet, G., van Damme, P., Brasseur, D., de Cuyper, X., Gregor, S., Holmberg, M., Martin, R., Molnar, Z., Pompa, M.G., Snacken, R., van der Se, M., van Ranst, M., Wirtz, A., Neels, P.